Avantax Advisory Services Inc. cut its position in shares of Haleon plc (NYSE:HLN – Free Report) by 17.2% during the fourth ...

In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...

Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...

This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...

(Alliance News) - Wellnex Life Ltd on Friday started trading on the AIM market in London. The Melbourne-based consumer healthcare company was already listed on the Australian Securities Exchange in ...

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

Bank of America says this constitutes the sharpest rotation out of the US and into Europe on record. The second banker said ...

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

Pfizer will get about $3.3 billion from its final stake sale in Haleon, according to a Wednesday filing with the London Stock ...

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.